Jordan v. Noven Pharmaceuticals Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Jordan v. Noven Pharmaceuticals Inc

Sort by

Viewing results 1‒25 of 51

Insider trading
Ex-Pfizer employee charged with insider trading over Covid treatment
...Joseph Dupont, then a vice-president at Alexion Pharmaceuticals, now owned by AstraZeneca, shared knowledge of an upcoming acquisition of Portola Pharmaceuticals with Shawn Cronin, a childhood friend and...
June 29, 2023
Covid-19 vaccines
Pfizer and Moderna forecast to almost double vaccine sales in 2022
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
October 18, 2021
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Covid-19 vaccines
Africa will pay more for Russian Covid vaccine than ‘western’ jabs
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
February 25, 2021
FT AlphavilleCoronavirus
The ESG case for the Oxford/AstraZeneca vaccine
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
December 23, 2020
Coronavirus treatment
EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
October 6, 2020
The Long ViewMichael Mackenzie
The coming earnings season could bring lofty stocks down to earth
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
July 11, 2020
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthPharmaceuticals sector
Crispr puts first human in-body gene editing to test
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
January 7, 2020
Jonathan Guthrie
The fallacy behind the rise of passive fund management
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
January 15, 2020
News in-depthMarkets14 min
How sneaker fans are cashing in on the $2bn resale market for limited edition trainers
...Virgin Louis V on my back, baby. Living fast, dying slow, that's the catch, baby. Suicide doors, [MUTED] around and crash, baby. I do the dash, baby....
October 22, 2019
News in-depthCushman & Wakefield Inc
Cushman v the cleaner: the fight over non-competes
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
October 16, 2018
Special Report50 Ideas to Change the World
Liver success holds promise of 3D organ printing
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
March 5, 2018
News in-depthThe Big Read
Quantum computing: the power to think outside the box
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
September 3, 2018
News in-depthThe Big Read
Big Tech vs Big Pharma: the battle over US patent protection
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
October 16, 2017
US & Canadian companies
Shire weighs spin-off for ADHD drugs division
...the neuroscience business should not “shock investors but is likely to raise a debate over possible use of proceeds should any cash be generated and management of any earnings dilution [ie deleveraging v...
August 3, 2017
Global Economy
New York bomb suspect arrested, blockchain challenge and man v machine
...(The Atlantic) Man v machine Sensitivity to “gut feelings” is a strong predictor of success in financial trading, according to research led by Cambridge university....
September 20, 2016
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
World
Hikma profits eroded by weaker generics business
...Hikma, the Jordan-founded but UK-listed drug maker, suffered a chunky drop in pre-tax profit in 2015, due in large part to a sharp decline in its generics business, where sales of a key gout medicine have...
March 16, 2016
Law
Top 10 innovative lawyers in North America
...Ms Reid specialises in patent law in the pharmaceutical industry. She draws on her scientific background to create intellectual property strategies that benefit biotech and pharmaceutical start-ups....
December 6, 2016
Mergers & Acquisitions
Hikma share drop accelerates
...Shareholders are taking a dim view of the gloomier assessment by Hikma Pharmaceutical of Roxane Laboratories, which it agreed to buy last year....
February 10, 2016
Mergers & Acquisitions
Hikma shares sink after it chops offer price for Roxane
...Jordan-founded but UK-listed Hikma initially agreed to buy the business from Boehringer Ingelheim in July, declaring that the deal would transform its scale and position in the US....
February 10, 2016
US downturn
Harley-Davidson brakes on lower shipment forecasts
...New York-listed shares of Israeli drugmaker Teva Pharmaceuticals rose more than 1 per cent to $64.16, after the company offered to buy US drugmaker Mylan....
April 21, 2015
News in-depthThe Big Read
Samsung: The activist v the ‘owners’
...Aberdeen Asset Management and Canada Pension Plan have also voiced opposition to the deal, as has the local company Ilsung Pharmaceuticals, which holds 2 per cent....
July 15, 2015
Energy sector
Drugmaker link-up puts Astra on top
...Lower down the drugs chain, Jordan-based Hikma Pharmaceuticals enjoyed second place on the mid-cap FTSE 250 index, rising 3 per cent to £17.42, after falling more than 6 per cent in the previous session...
August 21, 2014
beyondbricsJames Kynge
Fund Watch: EM healthcare is sole focus for Sectoral fund
...The fund’s approach is to invest only in EM healthcare companies (not their Western multinational counterparts) involved in pharmaceuticals, medical services and medical technology....
September 22, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group....
August 5, 2014
FT AlphavilleEquities
Guest post: The SEC could find new uses for an old law
...In at least one case, SEC v....
May 1, 2014

Previous pagePage 1 of 3Next page